Cartesian Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 3, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	195	461	107	-	-
Market Cap Growth	-60.27%	330.61%	-	-	-
Enterprise Value	64	256	123	-	-
Last Close Price	7.48	17.91	20.68	-	-
PS Ratio	178.28	11.84	4.12	-	-
PB Ratio	-	-67.74	-0.77	-	-
EV/Sales Ratio	58.41	6.58	4.75	-	-
Debt / Equity Ratio	-0.35	-2.06	-0.08	0.40	0.18
Debt / EBITDA Ratio	-	-	-	2.01	-
Net Debt / Equity Ratio	3.65	29.20	0.47	-1.03	-0.50
Net Debt / EBITDA Ratio	1.61	5.78	0.90	-6.11	1.03
Net Debt / FCF Ratio	1.90	6.06	1.28	2.95	0.06
Asset Turnover	0.00	0.11	0.11	1.26	-
Quick Ratio	10.44	9.29	1.26	5.76	6.38
Current Ratio	10.67	9.43	1.33	5.91	6.42
Return on Equity (ROE)	-	-	-	70.21%	-
Return on Assets (ROA)	-12.67%	-6.00%	-19.75%	10.35%	-
Return on Capital Employed (ROCE)	-23.40%	-8.60%	-31.40%	10.30%	-54.70%
Earnings Yield	-24.67%	-16.80%	-205.34%	-	-
FCF Yield	-35.42%	-7.11%	-48.01%	-	-
Buyback Yield / Dilution	-110.93%	-235.72%	-6.33%	-27.59%	-

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q